Ismail Guzelis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ismail Guzelis has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Aslı Subaşıoğlu
Department of Medical Genetics, Faculty of Medicine, Izmir Katip Celebi University , Izmir, Türkiye
1 shared publication - Aysegul Sari
Izmir Kâtip Celebi University, Türkiye
1 shared publication Betul Bolat Kucukzeybek
Department of Pathology Ataturk Training and Research Hospital, Izmir Katip Celebi University Izmir Turkey
1 shared publication- Cengiz Tavusbay
Department of General Surgery, İzmir Katip Çelebi University Atatürk Training and Research Hospital, İzmir, Turkey
1 shared publication - Dudu Solakoğlu Kahraman
Medical Pathology Department, Izmir Tepecik Training and Research Hospital, University of Health Sciences, Izmir, Turkey
1 shared publication - Duygu Ayaz
Department of Pathology, University of Health Sciences Tepecik Training and Research Hospital
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by Scientific Scholar in Cytojournal
- Vol. 23, 65
How successful are pap smear cytology and human papillomavirus DNA test in detecting high-grade squamous intraepithelial lesions in perimenopausal women?
Objectives: The World Health Organization and European Union are eager to eradicate cases of cervical cancer. Human papillomavirus (HPV) infection is the main cause of cervical cancer. A co-test consisting of high-risk HPV (hrHPV) DNA testing and Pap smear cytology is being performed in our center. Perimenopausal changes in cervical cytology can be worrisome, suggesting the presence of squamous intraepithelial lesions (SILs). In this study, we wanted to assess the value of hrHPV DNA testing and Pap smear cytology in the detection of high-grade SILs (HSILs). Material and Methods: A retrospective analysis of patients aged between 45 and 50 years was carried out. Between April 2021 and November 2024, cases who have undergone loop electrosurgical excision, conization, or biopsy of the cervix have been included in our study. Cases with priorly available Pap smear and HPV DNA test results were selected. Three different liquid-based cytology preparation methods were used during the time period involved in this study. Results: A total of 131 female cases were included in our study. The histopathological diagnoses were chronic or atrophic cervicitis in 12 (9.2%), low-grade SIL (LSIL) in 95 (72.5%), and HSIL in 24 (18.3%) cases. Of 24 HSIL cases, 16 were hrHPV DNA test positive. Pap smear test results of HSIL cases revealed 9 cases with atypical squamous cells of undetermined significance or LSIL, 8 cases with atypical squamous cells that could not exclude high-grade SIL (ASC-H) or LSIL+ASC-H, and 7 cases negative for intraepithelial lesion or malignancy (NILM). Seven HSIL cases with ≥ASC-H Pap smear result demonstrated HPV DNA-negativity. Six HSIL cases with positive HPV DNA test had a NILM Pap smear cytology result. Four of these discordant cases were signed out while a non-Food and Drug Administration-approved methodology was used. Conclusion: A proper methodology is essential for a high-standard Pap smear analysis. If only the HPV DNA test was used for screening, 7 HSIL cases would be missed. We believe that performing both tests concurrently provides the clinician invaluable data in the detection of cervical lesions.
- 13 October 2026
- Published by Scientific Scholar in Cytojournal
- Vol. 23, 65
Open AccessHow successful are pap smear cytology and human papillomavirus DNA test in detecting high-grade squamous intraepithelial lesions in perimenopausal women?
Objectives: The World Health Organization and European Union are eager to eradicate cases of cervical cancer. Human papillomavirus (HPV) infection is the main cause of cervical cancer. A co-test consisting of high-risk HPV (hrHPV) DNA testing and Pap smear cytology is being performed in our center. Perimenopausal changes in cervical cytology can be worrisome, suggesting the presence of squamous intraepithelial lesions (SILs). In this study, we wanted to assess the value of hrHPV DNA testing and Pap smear cytology in the detection of high-grade SILs (HSILs). Material and Methods: A retrospective analysis of patients aged between 45 and 50 years was carried out. Between April 2021 and November 2024, cases who have undergone loop electrosurgical excision, conization, or biopsy of the cervix have been included in our study. Cases with priorly available Pap smear and HPV DNA test results were selected. Three different liquid-based cytology preparation methods were used during the time period involved in this study. Results: A total of 131 female cases were included in our study. The histopathological diagnoses were chronic or atrophic cervicitis in 12 (9.2%), low-grade SIL (LSIL) in 95 (72.5%), and HSIL in 24 (18.3%) cases. Of 24 HSIL cases, 16 were hrHPV DNA test positive. Pap smear test results of HSIL cases revealed 9 cases with atypical squamous cells of undetermined significance or LSIL, 8 cases with atypical squamous cells that could not exclude high-grade SIL (ASC-H) or LSIL+ASC-H, and 7 cases negative for intraepithelial lesion or malignancy (NILM). Seven HSIL cases with ≥ASC-H Pap smear result demonstrated HPV DNA-negativity. Six HSIL cases with positive HPV DNA test had a NILM Pap smear cytology result. Four of these discordant cases were signed out while a non-Food and Drug Administration-approved methodology was used. Conclusion: A proper methodology is essential for a high-standard Pap smear analysis. If only the HPV DNA test was used for screening, 7 HSIL cases would be missed. We believe that performing both tests concurrently provides the clinician invaluable data in the detection of cervical lesions.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (2) , e20251212
Clinicopathological and genotypic characteristics of colorectal cancer patients carrying a germline MUTYH mutation
SUMMARY OBJECTIVE: Approximately 5–10% of the cases with colorectal cancers have a hereditary cancer syndrome. MUTYH is a DNA base excision repair gene, and its mutation can induce the development of polyposis and colorectal cancer. Additionally, MUTYH repair gene may interact with the DNA mismatch repair system. The aim of this study was to investigate the clinicopathological features of colorectal cancer cases carrying germline MUTYH mutations. METHODS: Among patients genetically tested using large hereditary cancer panels, data of those carrying germline MUTYH mutations were retrieved from the archive files. Then, the patients who had colorectal cancer were included in the study. RESULTS: Ten male and three female colorectal cancer patients with pathogenic (n=10) and variant of uncertain significance MUTYH mutations (n=3) were included in the study. While seven cases had homozygous MUTYH mutations, six patients carried heterozygous MUTYH mutations. The patients had c.800C>T p.P267L (n=4), c.1353_1355delGGA p.E452del (n=4), c.1087C>T p.Q363 (n=1), c.631G>A p.V211I (n=1), c.180A>G p.R60R (n=1), c.509G>A p.G170E (n=1) and c.650G>A p.R217H (n=1) mutations. The ascending colon was the most common site of involvement. Six cases with homozygous and one case with double heterozygous mutations had polyposis. Cases with homozygous (n=1) and heterozygous (n=1) MUTYH mutations were found to be MSH2-deficient. In both MSH2-deficient cases, the tumors were located in the ascending colon, and the case with a homozygous mutation had >100 polyps. CONCLUSION: Given that the MUTYH mutation is rarely seen in cases of colorectal cancers, we believe that our findings may contribute to identifying potential clinical and therapeutic implications for individuals with this mutation.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 72 (2) , e20251212
Open AccessClinicopathological and genotypic characteristics of colorectal cancer patients carrying a germline MUTYH mutation
SUMMARY OBJECTIVE: Approximately 5–10% of the cases with colorectal cancers have a hereditary cancer syndrome. MUTYH is a DNA base excision repair gene, and its mutation can induce the development of polyposis and colorectal cancer. Additionally, MUTYH repair gene may interact with the DNA mismatch repair system. The aim of this study was to investigate the clinicopathological features of colorectal cancer cases carrying germline MUTYH mutations. METHODS: Among patients genetically tested using large hereditary cancer panels, data of those carrying germline MUTYH mutations were retrieved from the archive files. Then, the patients who had colorectal cancer were included in the study. RESULTS: Ten male and three female colorectal cancer patients with pathogenic (n=10) and variant of uncertain significance MUTYH mutations (n=3) were included in the study. While seven cases had homozygous MUTYH mutations, six patients carried heterozygous MUTYH mutations. The patients had c.800C>T p.P267L (n=4), c.1353_1355delGGA p.E452del (n=4), c.1087C>T p.Q363 (n=1), c.631G>A p.V211I (n=1), c.180A>G p.R60R (n=1), c.509G>A p.G170E (n=1) and c.650G>A p.R217H (n=1) mutations. The ascending colon was the most common site of involvement. Six cases with homozygous and one case with double heterozygous mutations had polyposis. Cases with homozygous (n=1) and heterozygous (n=1) MUTYH mutations were found to be MSH2-deficient. In both MSH2-deficient cases, the tumors were located in the ascending colon, and the case with a homozygous mutation had >100 polyps. CONCLUSION: Given that the MUTYH mutation is rarely seen in cases of colorectal cancers, we believe that our findings may contribute to identifying potential clinical and therapeutic implications for individuals with this mutation.
- Open Access
- 30 October 2025
- Published by Scientific Scholar in Cytojournal
- Vol. 22, 89
A cytohistological correlation: Proliferative breast disease with atypia
Objective: Breast fine-needle aspiration cytology (FNAC) is a rapid, cost-effective, and minimally invasive diagnostic procedure. The diagnosis of a proliferative breast disease with atypia (PBDA) is established based on the presence of areas with disordered cellular arrangement and mildly discerned cytological features. We have aimed to explore the cytohistological correlation of PBDA on FNAC. Material and Methods: A review of the hospital database was undertaken to retrieve cases of breast FNAC diagnosed as PBDA between January 2011 and September 2020. Results: A total of 3125 breast FNAC specimens were examined, and 107 (3.4%) of them received the diagnosis of PBDA. A total of 68 PBDA cases were included in this cytohistological evaluation. The risk of malignancy was 44%. Except for one case, all of the invasive or microinvasive carcinomas were grade 1 or 2 malignancies according to the Nottingham grading system of breast cancers. The result of a repeat FNAC of the case with a poorly differentiated invasive breast cancer was reported as a high-grade malignancy. A statistically significant correlation was observed between older age and malignant outcome ( P < 0.001). Conclusion: This is one of the largest datasets of cases with PBDA. Based on the advanced age of the patient, and relevant clinical and radiological information, cytopathological diagnosis of PBDA may prompt the clinician to take further action.
- 30 October 2025
- Published by Scientific Scholar in Cytojournal
- Vol. 22, 89
Open AccessA cytohistological correlation: Proliferative breast disease with atypia
Objective: Breast fine-needle aspiration cytology (FNAC) is a rapid, cost-effective, and minimally invasive diagnostic procedure. The diagnosis of a proliferative breast disease with atypia (PBDA) is established based on the presence of areas with disordered cellular arrangement and mildly discerned cytological features. We have aimed to explore the cytohistological correlation of PBDA on FNAC. Material and Methods: A review of the hospital database was undertaken to retrieve cases of breast FNAC diagnosed as PBDA between January 2011 and September 2020. Results: A total of 3125 breast FNAC specimens were examined, and 107 (3.4%) of them received the diagnosis of PBDA. A total of 68 PBDA cases were included in this cytohistological evaluation. The risk of malignancy was 44%. Except for one case, all of the invasive or microinvasive carcinomas were grade 1 or 2 malignancies according to the Nottingham grading system of breast cancers. The result of a repeat FNAC of the case with a poorly differentiated invasive breast cancer was reported as a high-grade malignancy. A statistically significant correlation was observed between older age and malignant outcome ( P < 0.001). Conclusion: This is one of the largest datasets of cases with PBDA. Based on the advanced age of the patient, and relevant clinical and radiological information, cytopathological diagnosis of PBDA may prompt the clinician to take further action.
- Open Access
- 29 May 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (4) , 290-294
Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer
Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer - European Journal of Breast Health
- 29 May 2025
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 21 (4) , 290-294
Open AccessEvaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer
Evaluation of Tissue Expression of HMBG1 protein in Patients With Breast Cancer - European Journal of Breast Health
- 4 June 2024
- Published by Wiley in Diagnostic Cytopathology
- Vol. 52 (9) , E208-E214
HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature
Primary mucinous cystadenocarcinoma (MCA) of the breast is a rare variant of breast carcinoma. A 68‐year‐old female patient presented to the general surgery clinic with pain and swelling in the right breast. A mass was detected in the upper outer quadrant, and a fine‐needle aspiration biopsy was performed. The May‐Grünwald Giemsa stained slides showed aggregates of mucin‐rich pleomorphic cells with large nuclei in a mucinous background containing discohesive single cells. The Papanicolaou stain revealed a papillary structure composed of malignant epithelial cells in a necrotic background. A modified radical mastectomy was performed, and upon gross examination, two tumors were discovered in the central and upper outer quadrants. The first tumor, located centrally, was identified as invasive lobular breast carcinoma. The second tumor was an MCA with cytokeratin 7(+) and cytokeratin 20(−), and was determined to be the primary MCA of the breast based on clinical and radiological information. Immunohistochemistry revealed that the tumor cells were negative for estrogen receptor and progesterone receptor, and HER2 was 2+. Fluorescence in situ hybridization analysis detected HER2 gene amplification. During the 72‐month follow‐up, there were no findings compatible with recurrence or new metastasis. Although primary MCA is rare, it causes differential diagnosis problems and has different biological behaviors.
- 4 June 2024
- Published by Wiley in Diagnostic Cytopathology
- Vol. 52 (9) , E208-E214
HER2‐positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature
Primary mucinous cystadenocarcinoma (MCA) of the breast is a rare variant of breast carcinoma. A 68‐year‐old female patient presented to the general surgery clinic with pain and swelling in the right breast. A mass was detected in the upper outer quadrant, and a fine‐needle aspiration biopsy was performed. The May‐Grünwald Giemsa stained slides showed aggregates of mucin‐rich pleomorphic cells with large nuclei in a mucinous background containing discohesive single cells. The Papanicolaou stain revealed a papillary structure composed of malignant epithelial cells in a necrotic background. A modified radical mastectomy was performed, and upon gross examination, two tumors were discovered in the central and upper outer quadrants. The first tumor, located centrally, was identified as invasive lobular breast carcinoma. The second tumor was an MCA with cytokeratin 7(+) and cytokeratin 20(−), and was determined to be the primary MCA of the breast based on clinical and radiological information. Immunohistochemistry revealed that the tumor cells were negative for estrogen receptor and progesterone receptor, and HER2 was 2+. Fluorescence in situ hybridization analysis detected HER2 gene amplification. During the 72‐month follow‐up, there were no findings compatible with recurrence or new metastasis. Although primary MCA is rare, it causes differential diagnosis problems and has different biological behaviors.
- 27 December 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (2)
Memede Kollizyon Tümörü: Heterolog Komponentli Malign Filloides Tümör ve İnvaziv Meme Karsinomu, Spesifiye Edilemeyen Tip
- 27 December 2023
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 46 (2)
Memede Kollizyon Tümörü: Heterolog Komponentli Malign Filloides Tümör ve İnvaziv Meme Karsinomu, Spesifiye Edilemeyen Tip
- 22 September 2022
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 4 (3) , 293-296
Prognostic Significance of Tumor Budding in Urothelial Carcinomas of the Bladder: Comparison of Two Different Tumor Budding Evaluation Methods
Aim: In our study, we aimed to reveal the effect of tumor budding(TB) on prognosis in urothelial carcinomas and to compare the most commonly used alternative method (AM) and the International Tumor Budding Consensus Conference (ITBCC) system. TB can be easily assessed on routine hematoxylin and eosin-stained slides. In studies, TB was found to be associated with prognostic parameters in many organs. TB assessment in many organ cancers is based on ITBCC or alternatively different values used by different authors. Material and Method: Forty-eight urothelial cancers were obtained from 2010 to 2016 that was comprised of those having undergone surgical staging with a cystectomy or cystoprostatectomy and at least 5 years followed up. All hematoxylin and eosin-stained slides were re-evaluated for the status of TB according to ITBCC and AM. Results: According to ITBCC TB was not correlated with pT, lymphovascular invasion, lymph node involvement (LNI), tumor stage and 5-year mortality (p=0.102, p=0.722, p=0.165, p=0.431, p=0.524). According to AM, TB was more frequent as pT advanced, and was marginally associated with LNI (p=0.027, p=0.058). There was no relationship between TB and overall survival (p=0.130). Conclusion: We found the cut-off value in AM more useful than ITBCC recommendations. Although the association of TB with some of the prognostic parameters suggests that it may also be associated with prognosis, no relationship was found with overall survival. This may be related to the number of our cases.
- 22 September 2022
- Published by LookUs Bilisim A.S. in Medical Records
- Vol. 4 (3) , 293-296
Prognostic Significance of Tumor Budding in Urothelial Carcinomas of the Bladder: Comparison of Two Different Tumor Budding Evaluation Methods
Aim: In our study, we aimed to reveal the effect of tumor budding(TB) on prognosis in urothelial carcinomas and to compare the most commonly used alternative method (AM) and the International Tumor Budding Consensus Conference (ITBCC) system. TB can be easily assessed on routine hematoxylin and eosin-stained slides. In studies, TB was found to be associated with prognostic parameters in many organs. TB assessment in many organ cancers is based on ITBCC or alternatively different values used by different authors. Material and Method: Forty-eight urothelial cancers were obtained from 2010 to 2016 that was comprised of those having undergone surgical staging with a cystectomy or cystoprostatectomy and at least 5 years followed up. All hematoxylin and eosin-stained slides were re-evaluated for the status of TB according to ITBCC and AM. Results: According to ITBCC TB was not correlated with pT, lymphovascular invasion, lymph node involvement (LNI), tumor stage and 5-year mortality (p=0.102, p=0.722, p=0.165, p=0.431, p=0.524). According to AM, TB was more frequent as pT advanced, and was marginally associated with LNI (p=0.027, p=0.058). There was no relationship between TB and overall survival (p=0.130). Conclusion: We found the cut-off value in AM more useful than ITBCC recommendations. Although the association of TB with some of the prognostic parameters suggests that it may also be associated with prognosis, no relationship was found with overall survival. This may be related to the number of our cases.